French pharma association links with Bordeaux university
This article was originally published in Scrip
The French pharmaceutical industry association Leem and Victor Segalen University (Bordeaux 2) have signed a co-operation agreement that will help academics to tailor course offerings in life sciences to the real-world needs of pharmaceutical companies. The agreement formalises a longstanding relationship between the association and the university.
You may also be interested in...
Patents on Janssen-Cilag's (Johnson & Johnson) anti-epileptic Topamax/Epitomax (topiramate) expired in many European countries on September 25th, and generics companies are launching their own versions quickly.
Local health authorities in Coventry, UK, say it is most unlikely that vaccination with GlaxoSmithKline's Cervarix (human papillomavirus vaccine) was the cause of the death of a 14-year-old schoolgirl on September 28th.
Lilly's Alimta (pemetrexed) has been recommended as a first-line treatment for some patients in England and Wales with non-small cell lung cancer (NSCLC) in binding guidance for the national health service.